CorMedix Inc. (BOATS:CRMD) Financings
Financings
| Raise | Date |
|---|---|
| Convertible debt Closed: US$150M raised Buyers: Deerfield Use of proceeds: Funding the cash consideration for the acquisition of Melinta Therapeutics | Sep 2, 2025 |
| Public offering of shares of common stock Update: about US$85M · RBC Capital Markets +3 Dealers: RBC Capital Markets (lead), Truist Securities, Citizens Capital Markets, Needham & Company Use of proceeds: General corporate purposes, including working capital, research and product candidate development, and potential strategic transactions | Jun 27, 2025 |